The European Fee is demanding EU states take motion to stop a surge in Covid circumstances forward of the autumn and winter months.
On Friday (2 September), it launched a 15-page technique paper that goals to battle the virus that’s nonetheless killing some 2,300 individuals day by day all through the EU and Iceland, Liechtenstein and Norway.
Be part of EUobserver in the present day
Change into an professional on Europe
Get prompt entry to all articles — and 20 years of archives.
14-day free trial.
… or subscribe as a bunch
“The Covid-19 pandemic continues to be very a lot with us. Collectively, we should act in a coordinated technique to keep away from one other surge of circumstances,” mentioned Stella Kyriakides, EU well being commissioner, mentioned in a tweet.
The paper recommends, amongst different issues, that EU states enhance vaccine uptake and guarantee extra boosters for individuals in danger, together with these over the age of 60 or susceptible to any extreme illness.
The paper notes a tripling of circumstances over the summer season months, which has since tapered off, however stays excessive amongst individuals over the age of 65, and that vaccine uptake has barely modified.
Round 14 % of adults stay unvaccinated and simply over 35 % have but to obtain their first booster, it says.
The fee’s warning follows an announcement, by the European Medicines Company (EMA), that it had accredited two tailored variations of the Comirnaty and Spikevax vaccines.
These vaccines are designed to deal with completely different strains of the SARS‑CoV‑2 virus, to be able to develop the immune response.
“Each can be utilized to re-vaccinate individuals from 12 years of age we now have had their first two photographs of main vaccination,” the EMA’s Marco Cavaleri informed reporters on Friday.
The 2 adaptive vaccines are authorised for revaccination no matter the kind of jab individuals have acquired beforehand, he mentioned.
He additionally famous that each vaccines set off sturdy immune responses towards Omicron BA 1 and the unique virus in individuals beforehand vaccinated.
“Particularly, they have been more practical at triggering immune responses towards the BA.1 sub-variant than the unique vaccines,” he mentioned.
